Effectiveness Of Respiratory Syncytial Virus Immunoprophylaxis On Bronchiolitis Hospitalization Among High-Risk Infants

被引：0
|
作者：
Wu, P. [1 ]
Escobar, G. J. [2 ]
Gebretsadik, T. [3 ]
Carroll, K. [1 ]
Li, S. [2 ]
Walsh, E. [2 ]
Mitchel, E. [1 ]
Sloan, C. [4 ]
Dupont, W. [3 ]
Yu, C. [3 ]
Hartert, T. V. [1 ]
机构：
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[2] Kaiser Permanente Northern Calif, Oakland, CA USA
[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[4] Brigham Young Univ, Provo, UT 84602 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3029
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effectiveness of Respiratory Syncytial Virus Immunoprophylaxis in Reducing Bronchiolitis Hospitalizations Among High-Risk Infants
    Wu, Pingsheng
    Escobar, Gabriel J.
    Gebretsadik, Tebeb
    Carroll, Kecia N.
    Li, Sherian X.
    Walsh, Eileen M.
    Mitchel, Edward F.
    Sloan, Chantel
    Dupont, William D.
    Yu, Chang
    Horner, Jeffrey R.
    Hartert, Tina V.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2018, 187 (07) : 1490 - 1500
  • [2] Respiratory syncytial virus immunoprophylaxis in high-risk infants with heart disease
    Alexander, Peta M. A.
    Eastaugh, Lucas
    Royle, Jenny
    Daley, Andrew J.
    Shekerdemian, Lara S.
    Penny, Daniel J.
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2012, 48 (05) : 395 - 401
  • [3] Respiratory syncytial virus immunoprophylaxis in high-risk infants and development of childhood asthma
    Carroll, Kecia N.
    Gebretsadik, Tebeb
    Escobar, Gabriel J.
    Wu, Pingsheng
    Li, Sherian Xu
    Walsh, Eileen M.
    Mitchel, Ed
    Sloan, Chantel D.
    Dupont, William D.
    Hartert, Tina V.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (01) : 66 - +
  • [4] Clinical and Pharmacological Aspects of Immunoprophylaxis for Respiratory Syncytial Virus Infection in High-Risk Infants
    Lanari, Marcello
    Silvestri, Michela
    Rossi, Giovanni A.
    CURRENT DRUG METABOLISM, 2013, 14 (02) : 216 - 225
  • [5] Economic analyses of respiratory syncytial virus immunoprophylaxis in high-risk infants - A systematic review
    Kamal-Bahl, S
    Doshi, J
    Campbell, J
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2002, 156 (10): : 1034 - 1041
  • [6] Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
    Null, D
    Bimle, C
    Weisman, L
    Johnson, K
    Steichen, J
    Singh, S
    Wang, E
    Asztalos, E
    Loeffler, AM
    Azimi, PH
    Lieberman, JM
    O'Donnell, NE
    Cooke, RJ
    McCormick, K
    Koo, W
    Hammami, M
    Milner, AD
    Gaon, P
    Nachman, S
    Tarpey, KP
    Sánchez, PJ
    Broyles, RS
    Bratcher, D
    Ball, MV
    Duda, FJ
    DeCuir, PM
    Pollara, B
    Nelson, LS
    Balbus, M
    Schultz, MJ
    Chipps, BE
    Givner, LB
    O'Shea, M
    Everard, M
    Pfeffer, K
    Page, AJ
    Dennehy, PH
    Modlin, J
    Rhodes, T
    DeVincenzo, N
    Nickerson, B
    Arrieta, A
    Boucher, FD
    Keeney, RE
    Young, TE
    Stevens, JC
    Ariagno, R
    Adams, M
    Polak, MJ
    Lynch, SK
    PEDIATRICS, 1998, 102 (03) : 531 - 537
  • [7] Respiratory Syncytial Virus Bronchiolitis: Immunoprophylaxis and Clinical Management
    G Buonocore
    M L Tataranno
    S Negro
    S Perrone
    C V Bellieni
    D Palombo
    G Stazzoni
    M Tei
    A Mori
    A Picardi
    Pediatric Research, 2011, 70 : 625 - 625
  • [8] RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS: IMMUNOPROPHYLAXIS AND CLINICAL MANAGEMENT
    Buonocore, G.
    Tataranno, M. L.
    Negro, S.
    Perrone, S.
    Bellieni, C. V.
    Palombo, D.
    Stazzoni, G.
    Tei, M.
    Mori, A.
    Picardi, A.
    PEDIATRIC RESEARCH, 2011, 70 : 625 - 625
  • [9] Effectiveness of palivizumab immunoprophylaxis in infants with respiratory syncytial virus disease in Colombia
    Gabriel Pineros, Juan
    De la Hoz-Valle, Jose
    Galvis, Clara
    Celis, Astrid
    Ovalle, Oscar
    Cecilia Sandoval, Carmen
    Orrego, Jaime
    Vides, Saby
    Rojas, Iader
    Bustamante, Hernando
    Gallon, Carlos
    Alberto Mesa, Jaime
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (11): : 1708 - 1713
  • [10] Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses
    Wang, D.
    Bayliss, S.
    Meads, C.
    HEALTH TECHNOLOGY ASSESSMENT, 2011, 15 (05) : 1 - +
12345